AI in Cardiovascular Medicine: JACC Review

AI in Cardiovascular Medicine: JACC Review

  • Overview: This review discusses the use and future directions of AI in cardiology, focusing on areas like electrocardiography, telemetry and wearables, echocardiography, CMR, nuclear cardiology, CT, electrophysiology studies, coronary angiography, and genetics or multiomics.

  • AI Glossary: Includes key terms such as algorithms, AUC, artificial intelligence, neural networks, classification, CNNs, deep learning, features, foundation models, joint embedding, labels, large language models, machine learning, preprocessing, reinforcement learning, segmentation, semi-supervised learning, structured data, supervised learning, unstructured data, unsupervised learning, and wearables.

  • Deep Learning in Cardiology: Applied to physiologic waveform, imaging, and multiomics data with clinical applications. Studies reviewed using MeSH terms in PubMed.

  • ECG and AI: Deep learning techniques like CNNs show promise in arrhythmia classification and predicting conditions like LV systolic dysfunction, hypertrophic cardiomyopathy, and cardiac amyloidosis.

  • AI in Echocardiography: Improves image acquisition and interpretation, helping automate measurements and enhancing variability and disease diagnosis.

  • AI in CMR Imaging: Enhances image reconstruction, segmentation, and quantification. AI applications in nuclear cardiology and CT include improved prognostication and plaque burden quantification.

  • AI in Electrophysiology: Aids preprocedural planning, intraprocedural guidance, and postprocedural predictions, improving ablation target identification and therapy response prediction.

  • AI in Coronary Angiography: Automates stenosis detection, plaque characterization, and fractional flow reserve computation, enhancing accuracy and procedural efficiencies.

  • Machine Learning in Genomics: Improves risk prediction, variant interpretation, pathogenicity identification, and integration into clinical care.

  • Future of AI in Cardiovascular Medicine: Promises enhanced disease screening, imaging data integration, and accurate diagnoses. Focuses on data quality, diversity, model generalizability, and promoting AI adoption in clinical practice.

  • AI Potential: Significant potential to enhance patient care through improved diagnostics, risk stratification, and personalized treatment plans, supporting clinicians in delivering better cardiovascular care.

    Reference: J Am Coll Cardiol. 2024 Jun, 83 (24) 2472–2486

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(35)

REDUCE-AMI Trial: Diminishing Role of Beta-Blockers in ACS with preserved LVEF

REDUCE-AMI Trial: Diminishing Role of Beta-Blockers in ACS with preserved LVEF

1. The REDUCE-AMI trial showed no significant benefit of beta-blockers in reducing all-cause mortality or future myocardial infarction in patients with acute myocardial infarction and preserved left v...

24 Jun 20244min

Improving Left Ventricular Ejection Fraction in Heart Failure Patients: Insights from the HF-OPT Study

Improving Left Ventricular Ejection Fraction in Heart Failure Patients: Insights from the HF-OPT Study

The HF-OPT study investigated the improvement of left ventricular ejection fraction (LVEF) beyond 90 days in patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF). In this...

22 Jun 20245min

2024 ACC Peripheral Artery Disease (PAD) Guidelines

2024 ACC Peripheral Artery Disease (PAD) Guidelines

Collaborative vascular care is emphasized to address health disparities, gaps in medical therapy, structured exercise, and good foot care along with appropriate revascularization to prevent limb loss....

31 Mai 20246min

2024 ACC/AHA Guidelines on Hypertrophic Cardiomyopathy

2024 ACC/AHA Guidelines on Hypertrophic Cardiomyopathy

2024 HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise Mavacamten: Class 1 recommendation for symptomatic obstructive HCM. Exercise: Now allows for "vigorous" activity; competitive lev...

21 Mai 20249min

DOACs: When direct oral anticoagulants should not be used?

DOACs: When direct oral anticoagulants should not be used?

Key Points: Positive Aspects of DOACs: DOACs are acknowledged for their convenience, efficacy, and safety in conditions like atrial fibrillation (AF) and venous thromboembolism (VTE). The review sup...

29 Jan 20244min

Cath: NPO vs Eating before Heart Cath

Cath: NPO vs Eating before Heart Cath

Background: Traditional practice requires fasting before cardiac catheterization, but there's no evidence to support it. Objective: This study compared a heart-healthy pre-procedure diet with fasting ...

26 Jan 20243min

Stable CAD and Angina: PCI without medical therapy as first treatment (ORBITA-2)

Stable CAD and Angina: PCI without medical therapy as first treatment (ORBITA-2)

Key Points In patients not taking antianginal meds, PCI alleviated some—but not all—symptoms Background: Percutaneous coronary intervention (PCI) is commonly used to alleviate stable angina symptom...

22 Jan 20243min

Populært innen Helse

fastlegen
rss-gukild-johaug
hvordan-har-du-det-mann
psykodrama
lydartikler-fra-aftenposten
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-skravla-gar
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
foreldreradet
hjernesterk
morten-ramm-lar-kakla-ga-til-du-sovner
g-punktet
rss-loping-for-nybegynnere
klimaks
rss-garne-damer
treningsprat
kjed-deg-i-sovn-verdens-kjedeligste-podcast
rss-kunsten-a-leve
stetoskopet-tidsskriftets-podkast